Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1

Marc Bourlière, Stuart C. Gordon, Eugene R. Schiff, Tram T. Tran, Natarajan Ravendhran, Charles S. Landis, Robert H. Hyland, Luisa M. Stamm, Jie Zhang, Hadas Dvory-Sobol, G. Mani Subramanian, Diana M. Brainard, John G. McHutchison, Lawrence Serfaty, Alex J. Thompson, Thomas E. Sepe, Michael P. Curry, K. Rajender Reddy, Michael P. Manns

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1'. Together they form a unique fingerprint.

Medicine & Life Sciences